InvestorsHub Logo
Followers 30
Posts 2229
Boards Moderated 0
Alias Born 12/13/2016

Re: Jonjones325 post# 203557

Saturday, 07/27/2019 11:22:25 PM

Saturday, July 27, 2019 11:22:25 PM

Post# of 473260
JJ......the Consortium is quite an interesting grouping around the Neuronetrix ERP concept. On one end are Anavex and Cadent with no approved drugs but, intriguing and novel science for CNS and antipsychotic applications. Then there are Alkermers and Sage just beginning to bring to market the first of their drugs. And finally there are giants Lundbeck, Takeda and Merck covering Europe, Asia and the United States with mature pipelines and drugs on the market for CNS and Psychotic diseases. They all are interested in the ERP biomarker process, And, I daresay they are interested in what each one of them brings to the table. Suggest going on line to the companies website and see what they are into.....there is already collaboration in place. Did you know the original German Company, Merck, originated in the 1600's and that Lundbeck was a Danish hardware company originally.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News